Skip to content
value.today

Light Sciences Oncology Inc

🇺🇸 Bellevue, Washington, USABiotechnologyFounded 2004
Total raised
$45 M
4 rounds on record
Latest round
$2 M
Jan 2019
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Light Sciences Oncology Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2019$2 MNo. 4$2 to $10 million

Light Sciences Oncology Inc: Raise no. 4, Jan 2019

Investors in this round

6 investors had bought by the notice of Jan 18, 2019: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Llew Keltner · Executive Officer, Director
  • Robert Littauer · Executive Officer
  • Dennis Langer · Director
  • Edward Avedisian · Director
  • Mortimer Sackler · Director
  • Thomas Lavin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Littauer, Vp & cfo. Source: SEC Form D, newest notice filed Jan 18, 2019. Read the notice at the SEC.

equitySEC
Jan 2012$1 MNo. 3Under $2 million

Light Sciences Oncology Inc: Raise no. 3, Jan 2012

Investors in this round

11 investors had bought by the notice of Jan 23, 2012: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$222
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Dennis Langer · Executive Officer, Director
  • Lisa I. Koch-Hulle · Executive Officer
  • Robert M. Littauer · Executive Officer
  • Akbar Seddigh · Director
  • Jeff Himawan · Director
  • Martin Olin · Director
  • Peter Bisgaard · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert M. Littauer, Vice President and CFO. Source: SEC Form D, newest notice filed Jan 23, 2012. Read the notice at the SEC.

equitySEC
Jun 2011$6 MNo. 2$2 to $10 million

Light Sciences Oncology Inc: Raise no. 2, Jun 2011

Investors in this round

17 investors had bought by the notice of Jun 10, 2011: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
$925
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • Dennis P. Langer · Executive Officer, Director
  • James C. Chen · Executive Officer
  • Lisa I. Koch-Hulle · Executive Officer
  • Martin P. Olin · Executive Officer, Director
  • Robert M. Littauer · Executive Officer
  • Sy-Shi I. Wang · Executive Officer
  • Akbar P. Seddigh · Director
  • David P. Holveck · Director
  • Frank E. Young · Director
  • Jeff Himawan · Director
  • Mitchell P. Hymowitz · Director
  • Peter Bisgaard · Director
  • Terry Gould · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Total Offering Amount reflects a $5,000,000 credit facility that has been established and $1,256,000 that may be paid upon exercise of warrants. The issuer has not yet made a draw on the facility.”

Signed by Robert M Littauer, Vice President and CFO. Source: SEC Form D, newest notice filed Jun 10, 2011. Read the notice at the SEC.

debt, optionsSEC
Oct 2009$35 MNo. 1$10 to $50 million

Light Sciences Oncology Inc: Raise no. 1, Oct 2009

Investors in this round

17 investors had bought by the notice of Nov 5, 2009: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
$4,554
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Washington

People named in the notice

  • James C Chen · Executive Officer
  • Lisa C Koch-Hulle · Executive Officer
  • Llew Keltner, M.D. Ph.D. · Executive Officer, Director
  • Robert M Littauer · Executive Officer
  • S Erik C Hagstrom · Executive Officer
  • Sy-Shi C Wang · Executive Officer
  • Craig P Watjen · Director
  • David P Holveck · Director
  • Frank E Young, M.D., Ph.D. · Director
  • Jeff C Himawan, Ph.D. · Director
  • Martin P Olin · Director
  • Peter C Bisgaard · Director
  • Richard K Whitney · Director
  • Terry C Gould · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Total Offering Amount reflects a $23,347,833 credit facility that has been established and $11,745,990 that may be paid upon exercise of warrants. The Issuer has not yet made a draw on the facility.”

Signed by Robert M Littauer, Vice president, cfo, secretary and treasurer. Source: SEC Form D, newest notice filed Nov 5, 2009. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Light Sciences Oncology Inc chose not to state its revenue in its newest notice of a funding round (Jan 2019).

    SEC Form D · Jan 2019

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2019

That is all the official record says: Light Sciences Oncology Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Light Sciences Oncology Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Light Sciences Oncology Inc
NameRoleNamed in
Llew KeltnerExecutive officerJan 2019
Robert LittauerExecutive officerJan 2019
Dennis LangerExecutive officerJan 2012
Lisa I. Koch-HulleExecutive officerJan 2012
Robert M. LittauerExecutive officerJan 2012
Dennis P. LangerExecutive officerJun 2011
James C. ChenExecutive officerJun 2011
Martin P. OlinExecutive officerJun 2011
Sy-Shi I. WangExecutive officerJun 2011
James C ChenExecutive officerNov 2009
Lisa C Koch-HulleExecutive officerNov 2009
Llew Keltner, M.D. Ph.D.Executive officerNov 2009
Robert M LittauerExecutive officerNov 2009
S Erik C HagstromExecutive officerNov 2009
Sy-Shi C WangExecutive officerNov 2009
Dennis LangerDirectorJan 2019
Edward AvedisianDirectorJan 2019
Llew KeltnerDirectorJan 2019
Mortimer SacklerDirectorJan 2019
Thomas LavinDirectorJan 2019
Akbar SeddighDirectorJan 2012
Jeff HimawanDirectorJan 2012
Martin OlinDirectorJan 2012
Peter BisgaardDirectorJan 2012
Akbar P. SeddighDirectorJun 2011
David P. HolveckDirectorJun 2011
Dennis P. LangerDirectorJun 2011
Frank E. YoungDirectorJun 2011
Martin P. OlinDirectorJun 2011
Mitchell P. HymowitzDirectorJun 2011
Terry GouldDirectorJun 2011
Craig P WatjenDirectorNov 2009
David P HolveckDirectorNov 2009
Frank E Young, M.D., Ph.D.DirectorNov 2009
Jeff C Himawan, Ph.D.DirectorNov 2009
Llew Keltner, M.D. Ph.D.DirectorNov 2009
Martin P OlinDirectorNov 2009
Peter C BisgaardDirectorNov 2009
Richard K WhitneyDirectorNov 2009
Terry C GouldDirectorNov 2009